Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Database
Language
Document Type
Year range
1.
Clin Case Rep ; 9(4): 2285-2288, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1130470

ABSTRACT

This case highlights an atypical presentation of a patient with unknown history of mental disease who has been diagnosed with a bipolar disorder associated with severe COVID-19 symptoms. Neuroimaging was only positive for subtle white matter changes; he was treated with antipsychotics and mood-stabilizing agents until he reached partial remission. The authors urge clinicians to consider the impact of the COVID-19 pandemic on patients with mental illness and the urgent need for vigilant monitoring of presenting signs and symptoms.

2.
Clin Case Rep ; 9(2): 853-855, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-985978

ABSTRACT

The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.

3.
Clin Case Rep ; 9(1): 148-152, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-919869

ABSTRACT

The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment will prevent life-threatening bleeding and mortality.

SELECTION OF CITATIONS
SEARCH DETAIL